Navigating DCB 0129: A Guide for Health Tech Innovators

Hey there, health tech enthusiasts!

Today, we’re exploring DCB 0129, a crucial standard for anyone developing health IT systems or looking to sell into the UK healthcare sector. Whether you’re a seasoned developer or a newcomer, understanding DCB 0129 is key to ensuring your products are safe and compliant. 

 

This article answers some of the common questions and misconceptions we get asked on a daily basis – I hope it’s helpful! 

What is DCB 0129?

DCB 0129 is a standard developed by the NHS, providing a framework for manufacturers to demonstrate the clinical safety of their health IT products, essential for gaining trust and approval from healthcare organisations in the UK. 

Why is DCB 0129 Important to health tech developers?

The legal responsibility to comply with DCB 0129 should be reason enough, but clinical safety is so much more than a box-ticking exercise. Adhering to DCB 0129 assures healthcare organisations that your product is safe and reliable, positioning it as a trustworthy solution and unlocking new opportunities in the UK healthcare market. 

 

DCB 0129 is more than just a compliance & procurement requirement—it’s a badge of credibility. In the competitive health-tech market, showcasing that your innovation meets the highest safety standards helps you stand out. Applying clinical safety principles across your organisation ensures your product has undergone rigorous clinical risk management processes, preventing harm in healthcare settings. This builds confidence among potential buyers and users, making your product more attractive and trustworthy. 

The DCB Diamond© from BMS Digital Safety

Let me introduce you to the DCB Diamond© – a proven three step method to transform your product into a clinically verified, market ready, procurement friendly innovation!  

Figure 1: The DCB Diamond© - a three-step transformation programme from BMS Digital Safety

Ok, sounds good, but is it really needed?

Heard of health-tech software that has managed to get into the hands of doctors & nurses without achieving DCB 0129? 

 

Worryingly this does happen. Infrequently developers and even healthcare organisations manage to convince themselves that the standards don’t apply. 

 

News flash – if a product is involved in any aspect of patient care, even administrative, then it needs to be clinically safe. If a humble tongue depressor must demonstrate its risk profile so does the latest health tech! 

But my product is (or is not) a medical device…so surely the DCB Standards don’t apply to me?

Again, this is a common misconception. DCB 0129 is completely separate to the Medical Device Regs. There are strict rules governing Software as a Medical Device. The MHRA have produced a very handy flow chart as a first step to deciding if your innovation is a medical device or not. 

 

MHRA Software flowchart

Irrespective of the medical device status – DCB 0129 will still apply if the health-tech is involved in any clerical, administrative or clinical aspects of patient care. 

When should I start, and how long does it take?

Hopefully we’ve convinced you now that DCB 0129 is highly likely to apply to your health-tech innovation! 

 

So when should the risk management process start? Well, the simple answer is the sooner the better! Far too often we get parachuted in at the last moment, when the product is ready to (or already has) started to be used. This is too late, as any risk areas that are detected will need to be fixed – causing delay! 

 

It makes sense to start at the planning and prototype stage – when any issues can be easily and cheaply fixed.

What is involved in the Clinical Risk Management Process?

The risk management process outlined in DCB 0129 involves several key steps: 

 

Risk Identification & Analysis: Analyse the identified risks to determine their severity and likelihood. This helps prioritise which risks need the most attention. 

 

Risk Evaluation: For each identified hazard, the manufacturer must assess whether the initial clinical risk is acceptable. This assessment should be based on the risk acceptability criteria outlined in the Clinical Risk Management Plan [1] 

 

Risk Control: Implement measures to control or mitigate undesirable and unacceptable risks. This could involve design changes, additional safety features, or user training[1]. 

 

Risk Monitoring: Continuously monitor the system to ensure that the risk controls are effective and that new risks are identified and managed promptly [1].

Figure 2: The Clinical Risk Management Process - Risk Identification, Evaluation and Control. Adapted from Clinical Risk Management: its Application in the Manufacture of Health IT Systems - Implementation Guidance
Figure 3: The DCB 0129 Document Package

Getting Started – finding your Clinical Safety Officer

Let’s talk about why having an experienced, impartial Clinical Safety Officer (CSO) is vital for your health IT projects. Imagine trying to proofread your own work—it’s easy to miss those pesky typos, right? The same goes for spotting risks in your own product. That’s where a CSO comes in handy. They’re like your fresh pair of eyes, bringing an unbiased perspective to the clinical risk management process. 

 

All Clinical Safety Officers must be a registered clinician. Finding one who you trust, and that is going to take time to understand your product can be transformative. 

 

They understand the real-world impact of health IT systems and can evaluate risks effectively. This means they can spot potential issues that you might miss and ensure your product meets all the necessary safety standards – breaking down barriers to procurement and minimising risk to your company. 

 

In short, a skilled CSO helps make sure your health IT system is not only compliant with DCB 0129 but also genuinely safe for patients and healthcare providers. Think of them as your safety net, ensuring your product is ready to make a positive impact in the healthcare sector 

 

  1. Expertise in Risk Management: A skilled CSO understands the intricacies of clinical risk management and can guide your team through the DCB 0129 process[2]. 
  2. Compliance Assurance: They ensure that your product meets all necessary standards, reducing the risk of non-compliance and potential setbacks 
  3. Enhanced Safety: With a CSO on board, you can be confident that your product is safe for use in healthcare settings, protecting patients and healthcare providers alike 

In summary, DCB 0129 is a cornerstone for health technology developers aiming to succeed in the UK healthcare sector. Understanding and implementing its risk management process, along with having a proficient CSO, can significantly enhance your product’s safety and marketability. So, gear up and make DCB 0129 your ally in delivering safe and effective health IT solutions! 

 

Feel free to reach out if you have any questions or need further guidance on DCB 0129. 

 

References 

[1] DCB0129: Clinical Risk Management: its Application in the Manufacture … 

[2] CSO Council White Paper Digital clinical safety in the UK, an open and … 

[3] MHRA Software flowchart 

[4] What is the worth of a CSO? – BMS Digital Safety 

Discover more from BMS Digital Safety

Subscribe now to keep reading and get access to the full archive.

Continue reading